Your privacy is very important for us. When you visit our website, please agree to the use of all cookies. For more information about the processing of personal data, please go to Privacy policy

NEWS

Discover the latest updates on our firm and team here.

Keyword search

Sort by

Default

Input time DESC

Input time ASC

RuiMin advising AstraZeneca in acquisition of Gracell Biotechnologies Inc. furthering the AstraZeneca Cell Therapy

AstraZeneca (LSE/STO/Nasdaq: AZN) has recently entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, Nasdaq: GRCL). The proposed acquisition will enrich AstraZeneca’s growing pipeline of cell therapies.

12 January 2024